Home LiteratureArticle Details
PMID: 6143137 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Transient leucopenia associated with adult respiratory distress syndrome.

Lancet (London, England) ·Vol. 1 ·No. 8381 ·1984-04-14 ·Pages 809-12

Thommasen HV, Russell JA, Boyko WJ, Hogg JC

Abstract

The hypothesis that a change in white blood cell (WBC) count might be a useful predictor of the onset of adult respiratory distress syndrome (ARDS) was tested by monitoring total and differential WBC count in 40 patients at high risk of ARDS. ARDS developed in 10 patients and in 8 of these the systemic leucocyte count fell to less than 4200 cells/microliter. The other 2 patients showed a fall from 25 400 and 15 000 cells/microliter to 4500 and 6000 cells/microliter, respectively. Only 4 of the 30 patients in whom ARDS did not develop showed a fall to less than 4200 cells/microliter. The acute fall in WBC that was associated with the onset of severe respiratory failure indicates that frequent measurement of the leucocyte count in high-risk patients may be useful in identifying those in whom ARDS will develop.

MeSH Terms
Adult Complement Activation Female Humans Infant, Newborn Leukocyte Count Leukopenia/blood Male Middle Aged Neutrophils/immunology Oxygen/blood Platelet Count Respiratory Distress Syndrome, Newborn/blood,diagnosis Thrombocytopenia/blood Wounds and Injuries/complications
Chemicals
Oxygen
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Thommasen H V
Russell J A
Boyko W J
Hogg J C
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
1984-04-14
Pages
809-12
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]